Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 4—April 2002
Research

Genetic and Antigenic Analysis of the First A/New Caledonia/20/99-like H1N1 Influenza Isolates Reported in the Americas

Luke T. Daum*, Linda C. Canas*, Catherine B. Smith†, Alexander Klimov†, William Huff*, William Barnes*, and Kenton L. Lohman*Comments to Author 
Author affiliations: *Brooks Air Force Base, San Antonio, Texas, USA; †Centers for Disease Control and Prevention, Atlanta, Georgia, USA;

Main Article

Figure 2

An unrooted phylogenetic analysis of the HA1 gene nucleotide sequence of influenza A H1N1 viruses isolated since 1990. Peru isolates 1621 and 1798 are within the Beijing/262/95 lineage but are more similar to A/New Caledonia/20/99. A number of isolates characterized by Brooks Air Force Base from 1999 to 2001 were also A/NC/20/99-like. The tree was generated by using the Jotun-Hein algorithm (6) in MegAlign software (version 3.18). Horizontal lines are proportional to the number of substitutions between branch points. Asterisk (*) denotes 2000/01 vaccine strain; (1) denotes isolates characterized by Brooks Air Force Base. Brooks Air Force Base isolates are available from Genbank under accession numbers AF268312, AF268313 and AY029287-AY029292.

Figure 2. An unrooted phylogenetic analysis of the HA1 gene nucleotide sequence of influenza A H1N1 viruses isolated since 1990. Peru isolates 1621 and 1798 are within the Beijing/262/95 lineage but are more similar to A/New Caledonia/20/99. A number of isolates characterized by Brooks Air Force Base from 1999 to 2001 were also A/NC/20/99-like. The tree was generated by using the Jotun-Hein algorithm (6) in MegAlign software (version 3.18). Horizontal lines are proportional to the number of substitutions between branch points. Asterisk (*) denotes 2000/01 vaccine strain; (1) denotes isolates characterized by Brooks Air Force Base. Brooks Air Force Base isolates are available from Genbank under accession numbers AF268312, AF268313 and AY029287-AY029292.

Main Article

References
  1. Centers for Disease Control and Prevention. Influenza 2000. Available from: URL: http://www.cdc.gov/ncidod/diseases/flu/fluinfo.htm
  2. Breschkin  AM, Ahern  J, White  DO. Antigenic determinants of influenza virus hemagglutinin. Virology. 1981;113:130–40. DOIPubMedGoogle Scholar
  3. Caton  A, Brownlee  GG, Yewdell  JW, Gerhard  W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell. 1981;31:417–27. DOIGoogle Scholar
  4. Gerhard  W, Yewdell  J, Frankel  ME. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature. 1981;290:713–7. DOIPubMedGoogle Scholar
  5. Caton  AJ, Raymond  FL, Brownlee  GG, Yewdell  JW, Gerhard  W. Antigenic variation in influenza virus. Biochem Soc Trans. 1983;4:435–41.
  6. Canas  LC. The Department of Defense laboratory-based global influenza surveillance system. Mil Med 2000;165:Suppl 2.
  7. Williams  RJ, Cox  NJ, Regnery  HL, Noah  DL, Khan  AS, Miller  JM, Meeting the challenge of emerging pathogens: the role of the United States Air Force in global influenza surveillance. Mil Med. 1997;162:82–6.PubMedGoogle Scholar
  8. World Health Organization. Recommended composition of influenza virus vaccines for use in the 1997-1998 season. Wkly Epidemiol Rec. 1997;72:57–64.PubMedGoogle Scholar
  9. World Health Organization. Recommended composition of influenza virus vaccines for use in the 1998-1999 season. Wkly Epidemiol Rec. 1998;73:56–63.PubMedGoogle Scholar
  10. World Health Organization. Recommended composition of influenza virus vaccines for use in the 1999-2000 season. Wkly Epidemiol Rec. 1999;74:321–5.PubMedGoogle Scholar
  11. Kendal  AP, Pereura  MS, Skehel  J. Concepts and procedures for laboratory based influenza surveillance. Geneva, Switzerland: World Health Organization, 1982.
  12. Hein  JJ. Unified approach to alignment and phylogenies. Methods Enzymol. 1990;183:626–45. DOIPubMedGoogle Scholar
  13. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2000-2001 season. Wkly Epidemiol Rec. 2000;75:61–8.
  14. Wilson  IA, Cox  NJ. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol. 1990;8:737–71. DOIPubMedGoogle Scholar
  15. Raymond  FL, Caton  AJ, Cox  NJ, Kendal  AP, Brownlee  GG. Antigenicity and evolution of influenza J1 haemagglutinin, from 1950-1957 and 1977-1983: Two pathways form one gene. Virology. 1986;148:275–87. DOIPubMedGoogle Scholar
  16. Xu  X, Rocha  EP, Regenery  HL, Kendal  AP, Cox  NJ. Genetic and antigenic analysis of influenza a (H1N1) viruses, 1986-1991. Virus Res. 1990;28:37–55.
  17. Centers for Disease Control and Prevention. Update: influenza activity-United States, 1999-2000. MMWR Morb Mortal Wkly Rep. 2000;283:13.
  18. Centers for Disease Control and Prevention. Influenza activity—United States and Worldwide, April-October. MMWR Morb Mortal Wkly Rep. 2000;49:1006–8.PubMedGoogle Scholar
  19. Winter  G, Fields  S, Brownlee  GG. Nucleotide sequence of the haemagglutinin gene of influenza virus H1 subtype. Nature. 1981;292:72–5. DOIPubMedGoogle Scholar
  20. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2001-2002 season. Wkly Epidemiol Rec. 2001;76:58–61.PubMedGoogle Scholar
  21. Bush  RM, Bender  CA, Subbarao  K, Cox  NJ, Fitch  WM. Predicting the evolution of human influenza A. Science. 1999;286:1921–5. DOIPubMedGoogle Scholar
  22. Fitch  WM, Bush  RM, Bender  CA, Cox  NJ. Long term trends in the evolution of H(3) HA1 human influenza type A. Proc Natl Acad Sci U S A. 1997;94:7712–8. DOIPubMedGoogle Scholar

Main Article

Page created: July 15, 2010
Page updated: July 15, 2010
Page reviewed: July 15, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external